How many Ubrogepant clinical trials are there?

16 Ubrogepant clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 4 are actively recruiting participants. 10 are marked completed.

Are Ubrogepant clinical trials recruiting in 2026?

Yes — 4 Ubrogepant trials are actively recruiting in 2026, with 177 U.S. sites across 43 states. See the recruiting trials and the per-state site list further down this page.

What conditions is Ubrogepant being studied for?

Ubrogepant is being studied for Migraine, Migraine, With or Without Aura, Headache, Migraine, Healthy Volunteers, Interstitial Cystitis and 8 more. The trials are grouped by indication on this page.

What phase is Ubrogepant in?

Ubrogepant clinical trials span 3 Phase 4, 7 Phase 3, 4 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.

Who sponsors Ubrogepant clinical trials?

The lead sponsor across the most Ubrogepant trials is AbbVie, with 6 additional lead sponsors listed in the data. Each trial row links to the full study detail page including sponsor information.

Ubrogepant Clinical Trials (2026): 16 Studies for Migraine & Migraine, With or Without Aura

Creator: Hipa.ai Research
Published: 2026-05-08T19:36:01.399Z

Hipa.ai Research · Source: ClinicalTrials.gov / AACT

Synced daily from ClinicalTrials.gov via AACT. Last sync: June 18, 2026.

16 Ubrogepant clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 7 indications (including Migraine & Migraine, With or Without Aura) and 8,673 total planned enrollment. 7 Phase 3 Ubrogepant trials, 3 Phase 4 are listed. 4 Ubrogepant clinical trials are actively recruiting at 177 U.S. sites across 43 states. Most recent activity: NCT05127954 (Jan 2028).

Where to Participate: All Ubrogepant Trial Sites in the U.S. (177 sites across 43 states)

Every actively recruiting Ubrogepanttrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.

State	Facility	City	Trial	Map
AL	Rehabilitation & Neurological Services /ID# 229969	Huntsville35805-4046	NCT05125302	Map
AL	Rehabilitation and Neurological Services /ID# 275593	Huntsville35805	NCT06417775	Map
AL	The Center for Clinical Trials - Saraland /ID# 231546	Saraland36571	NCT05125302	Map
AZ	MD First Research - Chandler /ID# 262564	Chandler85286	NCT06417775	Map
AZ	Gilbert Neurology /ID# 260179	Gilbert85297	NCT06417775	Map
AZ	Foothills Research Center/CCT Research /ID# 260180	Phoenix85044	NCT06417775	Map
AZ	Velocity Clinical Research - Phoenix /ID# 274478	Phoenix85006	NCT05125302	Map
AR	HealthStar Research Glenwood /ID# 275303	Glenwood71943	NCT05125302	Map
AR	HealthStar Research of Hot Springs /ID# 273256	Hot Springs71913	NCT05125302	Map
AR	Preferred Research Partners /ID# 230725	Little Rock72211	NCT05125302	Map
AR	Preferred Research Partners /ID# 262786	Little Rock72211	NCT06417775	Map
CA	Advanced Research Center /ID# 227962	Anaheim92805	NCT05125302	Map
CA	Hope Clinical Research /ID# 257867	Canoga Park91303	NCT06417775	Map
CA	Axiom Research /ID# 257833	Colton92324	NCT06417775	Map
CA	Neuro Pain Research Center /ID# 227966	Fresno93710	NCT05125302	Map
CA	Neuro Pain Research Center /ID# 257155	Fresno93710	NCT06417775	Map
CA	Axiom Research, LLC-Los Angeles /ID# 264085	Glendale91206	NCT06417775	Map
CA	Sun Valley Research Center /ID# 257152	Imperial92251-9401	NCT06417775	Map
CA	Axiom Research - Irvine /ID# 264083	Irvine92604	NCT06417775	Map
CA	Alliance for Research Alliance for Wellness /ID# 230546	Long Beach90807	NCT05125302	Map
CA	BNL Health - Los Angeles Headache Center /ID# 257237	Los Angeles90067-2001	NCT06417775	Map
CA	M3 Wake Research - Newport Beach /ID# 257158	Newport Beach92660	NCT06417775	Map
CA	Excell Research, Inc /ID# 230899	Oceanside92056	NCT05125302	Map
CA	Artemis Institute for Clinical Research - San Diego /ID# 257134	San Diego92103-2204	NCT06417775	Map
CA	M3 Wake Research - Convoy /ID# 257897	San Diego92111	NCT06417775	Map
CA	Paradigm Clinical Research - San Diego /ID# 269608	San Diego92108-1681	NCT05125302	Map
CA	Optimus Medical /ID# 257856	San Francisco94102	NCT06417775	Map
CA	Lumos Clinical Research Center /ID# 231267	San Jose95124-4108	NCT05125302	Map
CA	Sunwise Clinical Research /ID# 230971	Walnut Creek94596	NCT05125302	Map
CA	Amicis Research Center /ID# 272621	Winnetka91306	NCT05125302	Map
CO	Children's Hospital Colorado - Aurora /ID# 231879	Aurora80045	NCT05125302	Map
CT	New England Institute for Clinical Research /ID# 230635	Stamford06905	NCT05125302	Map
CT	New England Institute for Clinical Research /ID# 264019	Stamford06905	NCT06417775	Map
DC	Emerson Clinical Research Institute - Connecticut Avenue - Washington /ID# 231693	Washington D.C.20009	NCT05125302	Map
FL	Neurology Offices of South Florida, PLLC /ID# 257161	Boca Raton33428-2231	NCT06417775	Map
FL	Encore Medical Research of Boynton Beach LLC /ID# 246833	Boynton Beach33436-7245	NCT05125302	Map
FL	Accel Research Sites Network - DeLand Clinical Research Unit /ID# 257403	DeLand32720	NCT06417775	Map
FL	Gulf Coast Clinical Research Center /ID# 230020	Fort Myers33912	NCT05125302	Map
FL	AGA Clinical Trials /ID# 230554	Hialeah33012	NCT05125302	Map
FL	Encore Medical Research /ID# 245682	Hollywood33021	NCT05125302	Map
FL	Accel Research Sites - Lakeland Clinical Research Unit /ID# 257874	Lakeland33803	NCT06417775	Map
FL	Columbus Clinical Services, Llc /Id# 230880	Miami33125	NCT05125302	Map
FL	My Preferred Research LLC /ID# 227886	Miami33155	NCT05125302	Map
FL	Well Pharma Medical Research /ID# 257199	Miami33143	NCT06417775	Map
FL	Indago Research and Health Center /ID# 277943	Miami Lakes33016	NCT06417775	Map
FL	Sensible Healthcare /ID# 257198	Ocoee34761	NCT06417775	Map
FL	Medical Research Group of Central Florida /ID# 231632	Orange City32763	NCT05125302	Map
FL	Clinical Associates of Orlando, LLC /ID# 272619	Orlando32819	NCT05125302	Map
FL	Asclepes Research Centers - Spring Hill /ID# 229815	Spring Hill34609-5692	NCT05125302	Map
FL	University of South Florida- Neuroscience Institute /ID# 229324	Tampa33613	NCT05125302	Map
FL	Encore Medical Research - Weston /ID# 246809	Weston33331	NCT05125302	Map
FL	Conquest Research /ID# 258314	Winter Park32789	NCT06417775	Map
FL	Pediatric Neurology and Epilepsy Specialists /ID# 229967	Winter Park32789-7111	NCT05125302	Map
GA	Clinical Integrative Research Center of Atlanta (CIRCA) /ID# 231134	Atlanta30328	NCT05125302	Map
GA	NeuroTrials Research /ID# 274507	Atlanta30328	NCT06417775	Map
GA	Rare Disease Research /ID# 231046	Atlanta30318-2512	NCT05125302	Map
GA	Coastal Georgia Child Neurology /ID# 231409	Brunswick31520-1601	NCT05125302	Map
GA	CenExcel iResearch LLC /ID# 227903	Decatur30030	NCT05125302	Map
GA	Velocity Clinical Research - Savannah. /ID# 228992	Savannah31406	NCT05125302	Map
GA	Clinical Research Atlanta - Headlands LLC /ID# 260181	Stockbridge30281-9054	NCT06417775	Map
HI	Hawaii Pacific Neuroscience /ID# 274469	Honolulu96817	NCT06417775	Map
ID	Velocity Clinical Research - Boise /ID# 231871	Meridian83642	NCT05125302	Map
ID	Velocity Clinical Research - Boise /ID# 257135	Meridian83642	NCT06417775	Map
IL	Chicago Headache Center & Research Institute /ID# 248625	Chicago60657	NCT05125302	Map
IL	Ascension Saint Alexius /ID# 275261	Hoffman Estates60169	NCT05125302	Map
IL	Healthcare Research Network /ID# 257868	Tinley Park60477	NCT06417775	Map
IN	Deaconess Midtown Hospital /ID# 257400	Evansville47710	NCT06417775	Map
IA	Accellacare - McFarland Clinic /ID# 229789	Ames50010	NCT05125302	Map
IA	Accellacare - McFarland Clinic /ID# 257834	Ames50010	NCT06417775	Map
KS	Alliance for Multispecialty Research LLC /ID# 257839	Newton67114	NCT06417775	Map
KS	Clinical Associates Midwest, LLC /ID# 274315	Overland Park66214	NCT05125302	Map
KS	Collective Medical Research /ID# 257131	Overland Park66210	NCT06417775	Map
KS	Alliance For Multispeciality Research - Wichita East /ID# 257148	Wichita67207	NCT06417775	Map
KS	Alliance for Multispecialty Research - Wichita East /ID# 234126	Wichita67207	NCT05125302	Map
KY	University of Kentucky Chandler Medical Center. /ID# 230827	Lexington40536	NCT05125302	Map
LA	IMA Clinical Research Monroe - Wood /ID# 259362	Monroe71201	NCT06417775	Map
MD	Headlands PharmaSite /ID# 257208	Baltimore21208	NCT06417775	Map
MD	Pharmasite Research, Inc. /ID# 227908	Baltimore21208	NCT05125302	Map
MA	Boston Clinical Trials /ID# 257132	Boston02131-2515	NCT06417775	Map
MA	MedVadis Research /ID# 257156	Waltham02451	NCT06417775	Map
MI	Michigan Headache & Neurological Institute (MHNI) /ID# 257179	Ann Arbor48104-5131	NCT06417775	Map
MI	Memorial Healthcare Institute For Neuroscience /ID# 274663	Owosso48867	NCT06417775	Map
MN	Minneapolis Clinic of Neurology - Burnsville /ID# 232551	Burnsville55337-6732	NCT05125302	Map
MS	Proven Endpoints LLC /ID# 239513	Ridgeland39157	NCT05125302	Map
MS	Proven Endpoints LLC /ID# 273796	Ridgeland39157	NCT06417775	Map
MO	HealthCare Research Network - Hazelwood /ID# 257402	Hazelwood63042	NCT06417775	Map
MO	Sharlin Health and Neurology /ID# 229523	Ozark65721	NCT05125302	Map
MO	Clinvest Research LLC /ID# 257215	Springfield65807	NCT06417775	Map
NE	Cognitive Clinical Trials (CCT) - Papillion /ID# 232552	Papillion68046-4131	NCT05125302	Map
NE	Cognitive Clinical Trials (CCT) - Papillion /ID# 260174	Papillion68046-4131	NCT06417775	Map
NV	Wr-Crcn, Llc /Id# 257895	Las Vegas89118-2557	NCT06417775	Map
NH	Healthy Perspectives - Innovative Mental Health Services, PLLC /ID# 230312	Nashua03060-3483	NCT05125302	Map
NJ	Goryeb Childrens Hospital /ID# 229507	Morristown07960	NCT05125302	Map
NJ	Bio Behavioral Health, Inc /ID# 257140	Toms River08755-6434	NCT06417775	Map
NJ	IMA Clinical Research Warren /ID# 263641	Warren Township07059	NCT06417775	Map
NM	Albuquerque Clinical Trials, Inc. /ID# 257212	Albuquerque87102	NCT06417775	Map
NY	Dent Neurologic Institute - Amherst /ID# 231182	Amherst14226	NCT05125302	Map
NY	Dent Neurologic Institute - Amherst /ID# 257219	Amherst14226	NCT06417775	Map
NY	IMA Clinical Research Westchester /ID# 259157	Hartsdale10530	NCT06417775	Map
NY	Fieve Clinical Research, Inc. /ID# 257177	New York10017-1921	NCT06417775	Map
NY	Rochester Clinical Research /ID# 257193	New York14609	NCT06417775	Map
NY	True North Neurology /ID# 274672	Port Jefferson Station11776	NCT06417775	Map
NY	SUNY Upstate Medical University /ID# 239898	Syracuse13210	NCT05125302	Map
NY	Upstate Clinical Research Associates /ID# 257163	Williamsville14221-6046	NCT06417775	Map
NC	Headache Wellness Center /ID# 257136	Greensboro27405	NCT06417775	Map
NC	Accellacare - South Hawthorne Road - Winston-Salem /ID# 257731	Winston-Salem27103	NCT06417775	Map
NC	Accellacare - South Hawthorne Road - Winston-Salem /ID# 257850	Winston-Salem27103	NCT06417775	Map
OH	Cincinnati Childrens Hospital Medical Center /ID# 244689	Cincinnati45229	NCT05125302	Map
OH	CTI Clinical Research Center /ID# 257162	Cincinnati45212-3784	NCT06417775	Map
OH	Headache Center of Hope /ID# 242645	Cincinnati45236-1875	NCT05125302	Map
OH	Patient Priority Clinical Sites, LLC /ID# 238485	Cincinnati45215-2123	NCT05125302	Map
OH	University Of Cincinnati Medical Center /ID# 231199	Cincinnati45219	NCT05125302	Map
OH	C7 Research /ID# 272815	Cleveland44109	NCT06417775	Map
OH	Centricity Research Columbus /ID# 231181	Columbus43213	NCT05125302	Map
OH	Centricity Research Columbus /ID# 257221	Columbus43213	NCT06417775	Map
OH	Wright State Physicians Health Center /ID# 274708	Fairborn45324	NCT06417775	Map
OH	CincyScience /ID# 230046	West Chester45069	NCT05125302	Map
OK	Lynn Institute of Oklahoma City /ID# 257857	Oklahoma City73112	NCT06417775	Map
OK	Central States Research /ID# 277867	Tulsa74136	NCT06417775	Map
OR	Providence Brain and Spine Institute /ID# 231607	Portland97225-6625	NCT05125302	Map
OR	Summit Research Network - Portland - Northwest Vaughn Street /ID# 257139	Portland97210	NCT06417775	Map
PA	Abington Neurological Associates - Abington /ID# 257164	Abington19001	NCT06417775	Map
PA	Children's Hospital of Philadelphia - Main /ID# 232487	Philadelphia19104-4319	NCT05125302	Map
PA	Clinical Research of Philadelphia, LLC /ID# 257197	Philadelphia19114	NCT06417775	Map
PA	Frontier Clinical Research - Scottdale /ID# 231913	Scottdale15683	NCT05125302	Map
PA	Frontier Clinical Research - Smithfield /ID# 231912	Smithfield15478	NCT05125302	Map
RI	Partners In Clinical Research /ID# 257855	Cumberland02864	NCT06417775	Map
SC	Premier Neurology /ID# 260359	Greenville29605	NCT06417775	Map
SC	Tribe Clinical Research LLC /ID# 230422	Greenville29607-4021	NCT05125302	Map
SC	Coastal Carolina Research Center - North Charleston /ID# 257227	North Charleston29405	NCT06417775	Map
TN	WR-ClinSearch /ID# 257160	Chattanooga37421-1605	NCT06417775	Map
TN	KCA Neurology /ID# 274495	Franklin37067	NCT06417775	Map
TN	Alliance for Multispecialty Research - Knoxville /ID# 257846	Knoxville37920	NCT06417775	Map
TN	Access Clinical Trials, Inc. /ID# 228002	Nashville37203	NCT05125302	Map
TX	Austin Regional Clinic - ARC Four Points /ID# 276301	Austin78726	NCT05125302	Map
TX	FutureSearch Trials of Neurology /ID# 257186	Austin78731	NCT06417775	Map
TX	UT Health Austin at Dell Children's Neurology Clinic /ID# 244266	Austin78723-3079	NCT05125302	Map
TX	Velocity Clinical Research, Austin /ID# 230557	Austin78759	NCT05125302	Map
TX	Tekton Research - Beaumont /ID# 231207	Beaumont77706-3067	NCT05125302	Map
TX	Cedar Health Research /ID# 228003	Dallas75251-2202	NCT05125302	Map
TX	FutureSearch Trials of Dallas, LP /ID# 257142	Dallas75231	NCT06417775	Map
TX	Relaro Medical Trials /ID# 239642	Dallas75243	NCT05125302	Map
TX	Epic Medical Research - DeSoto /ID# 274314	DeSoto75115	NCT05125302	Map
TX	Innovare Research Group, LLC /ID# 277617	Friendswood77546	NCT05125302	Map
TX	Aavon Clinical Trials /ID# 279007	Houston77074	NCT05125302	Map
TX	DM Clinical Research /ID# 229826	Houston77065	NCT05125302	Map
TX	Elevate Clinical - Seabrook /ID# 274679	Houston77058	NCT06417775	Map
TX	Houston Clinical Research Associates /ID# 244889	Houston77090-2633	NCT05125302	Map
TX	Houston Clinical Research Associates /ID# 272077	Houston77090	NCT06417775	Map
TX	Pioneer Research Solutions - Houston - Stancliff Road /ID# 274316	Houston77099	NCT05125302	Map
TX	Sante Clinical Research /ID# 246503	Kerrville78028-9640	NCT05125302	Map
TX	Red Star Research, LLC /ID# 257871	Lake Jackson77566	NCT06417775	Map
TX	FMC Science /ID# 231915	Lampasas76550	NCT05125302	Map
TX	Radiance Clinical Research /ID# 271727	Lampasas76550	NCT06417775	Map
TX	Epic Clinical Research - Lewisville /ID# 274480	Lewisville75057	NCT06417775	Map
TX	Livingspring Family Medical Center /ID# 249869	Mansfield76063-5622	NCT05125302	Map
TX	Sms Clinical Research /ID# 278443	Mesquite75149	NCT06417775	Map
TX	Road Runner Research /ID# 230527	San Antonio78249-3538	NCT05125302	Map
TX	ClinPoint Trials /ID# 230295	Waxahachie75165-1430	NCT05125302	Map
UT	Pantheon Clinical Research /ID# 250703	Bountiful84010-4968	NCT05125302	Map
UT	Foothill Family Draper Clinic /ID# 277876	Draper84020	NCT06417775	Map
UT	Advanced Research Institute /ID# 257853	Ogden84405	NCT06417775	Map
UT	Highland Clinical Research /ID# 239362	Salt Lake City84124	NCT05125302	Map
UT	Highland Clinical Research /ID# 257137	Salt Lake City84124	NCT06417775	Map
UT	J. Lewis Research, Inc. / Foothill Family Clinic South /ID# 258305	Salt Lake City84121-6923	NCT06417775	Map
VA	Charlottesville Medical Research /ID# 257154	Charlottesville22911	NCT06417775	Map
VA	Alliance for Multispecialty Research - Clinical Research Associates /ID# 257851	Norfolk23502	NCT06417775	Map
VA	Children's Hospital of The King's Daughters - Children's Medical Tower /ID# 230581	Norfolk23507-1901	NCT05125302	Map
WA	Northwest Clinical Research Center /ID# 257381	Bellevue98007	NCT06417775	Map
WA	Core Clinical Research /ID# 227904	Everett98201	NCT05125302	Map
WA	MultiCare Institute for Research and Innovation /ID# 231061	Tacoma98405	NCT05125302	Map
WA	Puget Sound Neurology /ID# 257174	Tacoma25328	NCT06417775	Map
WV	Vaught Neurological Services /ID# 267519	Beckley25801	NCT06417775	Map
WV	Frontier Clinical Research - Kingwood /ID# 231914	Kingwood26537-9797	NCT05125302	Map
WV	West Virginia Univ School Med /ID# 258898	Morgantown26506	NCT06417775	Map
WI	Mind+ Neurology /ID# 274486	Mequon53092	NCT06417775	Map
WI	Mind+ Neurology /ID# 275529	Mequon53092	NCT05125302	Map

Ubrogepant clinical trials at a glance: phase × recruitment status

Phase	recruiting	active not recruiting	enrolling by invitation	completed	terminated	Total
P1				4		4
P3	2		1	4		7
P4		1		1	1	3
N/A			1	1		2

Recruiting Ubrogepant clinical trials (4)

Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).

NCT ID	Title	Phase	Indication	Enrollment	Started
NCT05127954	UBRO PEDS OLELong-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Pediatric Participants (Ages 6-17)	P3	Migraine	1,200	Jan 2022
NCT06417775	UBRO MMStudy of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine	P3	Migraine	496	Sep 2024
NCT05125302	Ubro PedsStudy to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)	P3	Migraine	1,059	Jan 2022
NCT06212661	Migraine Medication Effects on Urinary Symptoms	—	Overactive Bladder	200	Apr 2024

Ubrogepant clinical trials by indication

Migraine (8)

NCT	Acronym	Phase	Status	Title
NCT05127954	UBRO PEDS OLE	P3	enrolling by invitation	Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Pediatric Participants (Ages 6-17)
NCT06417775	UBRO MM	P3	recruiting	Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
NCT05125302	Ubro Peds	P3	recruiting	Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
NCT06578585	—	P1	completed	A Trial Investigating Lu AG09222 With Ubrogepant in Participants With Migraine
NCT05654298	—	N/A	completed	Influence of Ubrogepant and Sumatriptan on the Dermal Blood Flow Response to Histamine, Cinnamaldehyde and Capsaicin
NCT04492020	UBR Prodrome	P3	completed	Study to Evaluate Oral Ubrogepant in the Acute Treatment of Migraine During the Prodrome in Adult Participants
NCT04818515	—	P1	completed	Study To Assess Adverse Events and Drug to Drug Interaction of Oral Tablet Atogepant and Ubrogepant in Adult Participants With a History of Migraine
NCT04179474	—	P1	completed	Safety, Tolerability and Drug- Drug Interaction Study of Ubrogepant With Erenumab or Galcanezumab in Participants With Migraine

Migraine, With or Without Aura (3)

NCT	Acronym	Phase	Status	Title
NCT02873221	—	P3	completed	An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine
NCT02867709	ACHIEVE II	P3	completed	Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine
NCT02828020	ACHIEVE I	P3	completed	Efficacy, Safety, and Tolerability Study of Oral Ubrogepant in the Acute Treatment of Migraine

Overactive Bladder (1)

NCT	Acronym	Phase	Status	Title
NCT06212661	—	N/A	enrolling by invitation	Migraine Medication Effects on Urinary Symptoms

Healthy Volunteers (1)

NCT	Acronym	Phase	Status	Title
NCT05892757	—	P1	completed	Study to Assess Adverse Events and Compare How Oral Ubrogepant and Oral Atogepant Moves Through the Body of Healthy Female Adult Volunteers

Headache, Migraine (1)

NCT	Acronym	Phase	Status	Title
NCT05503082	UNION	P4	active not recruiting	Ubrogepant treatmeNt in mIgraine Patients Utilizing mOnoclonal aNtibodies

Migraine With Aura (1)

NCT	Acronym	Phase	Status	Title
NCT05214001	ATOM	P4	terminated	Evaluation of the Efficacy of Almotriptan and Ubrogepant for the Acute Treatment of Migraine

Episodic Migraine (1)

NCT	Acronym	Phase	Status	Title
NCT05264129	TANDEM	P4	completed	Study to Assess Adverse Events When Ubrogepant Tablets in Combination With Atogepant Tablets Are Used to Treat Adult Participants With Migraine

Ubrogepant pivotal trial highlights (Phase 2/3/4)

Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.

Acronym	NCT	Phase	Status	Indication	Enrollment	PubMed
UNION	NCT05503082	P4	active not recruiting	Headache, Migraine	164	PMID 32073660
ATOM	NCT05214001	P4	terminated	Migraine With Aura	8	—
TANDEM	NCT05264129	P4	completed	Episodic Migraine	263	PMID 39569702
UBRO PEDS OLE	NCT05127954	P3	enrolling by invitation	Migraine	1,200	—
UBRO MM	NCT06417775	P3	recruiting	Migraine	496	—
Ubro Peds	NCT05125302	P3	recruiting	Migraine	1,059	—
UBR Prodrome	NCT04492020	P3	completed	Migraine	518	PMID 39399572
ACHIEVE II	NCT02867709	P3	completed	Migraine, With or Without Aura	1,686	PMID 35468729
ACHIEVE I	NCT02828020	P3	completed	Migraine, With or Without Aura	1,672	PMID 36125279

Terminated and withdrawn Ubrogepant trials (1)

Studies that ended before completion. Reasons are filed in each trial's ClinicalTrials.gov entry.

NCT05214001terminatedEvaluation of the Efficacy of Almotriptan and Ubrogepant for the Acute Treatment of Migraine

All Ubrogepant trials (16)

Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.

NCT ID	Acronym	Title	Phase	Status	Enrollment	Sponsor	Started
NCT05127954	UBRO PEDS OLE	Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Pediatric Participants (Ages 6-17)	P3	enrolling by invitation	1,200	AbbVie	Jan 2022
NCT06417775	UBRO MM	Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine	P3	recruiting	496	AbbVie	Sep 2024
NCT05125302	Ubro Peds	Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)	P3	recruiting	1,059	AbbVie	Jan 2022
NCT06212661		Migraine Medication Effects on Urinary Symptoms	—	enrolling by invitation	200	The Cleveland Clinic	Apr 2024
NCT06578585		A Trial Investigating Lu AG09222 With Ubrogepant in Participants With Migraine	P1	completed	43	H. Lundbeck A/S	Sep 2024
NCT05503082	UNION	Ubrogepant treatmeNt in mIgraine Patients Utilizing mOnoclonal aNtibodies	P4	active not recruiting	164	Chicago Headache Center & Research Institute	Sep 2022
NCT05214001	ATOM	Evaluation of the Efficacy of Almotriptan and Ubrogepant for the Acute Treatment of Migraine	P4	terminated	8	Messoud Ashina, MD	Jun 2022
NCT05892757		Study to Assess Adverse Events and Compare How Oral Ubrogepant and Oral Atogepant Moves Through the Body of Healthy Female Adult Volunteers	P1	completed	24	AbbVie	Jul 2023
NCT05264129	TANDEM	Study to Assess Adverse Events When Ubrogepant Tablets in Combination With Atogepant Tablets Are Used to Treat Adult Participants With Migraine	P4	completed	263	AbbVie	Mar 2022
NCT05654298		Influence of Ubrogepant and Sumatriptan on the Dermal Blood Flow Response to Histamine, Cinnamaldehyde and Capsaicin	N/A	completed	20	Universitaire Ziekenhuizen KU Leuven	Mar 2022
NCT04492020	UBR Prodrome	Study to Evaluate Oral Ubrogepant in the Acute Treatment of Migraine During the Prodrome in Adult Participants	P3	completed	518	AbbVie	Aug 2020
NCT04818515		Study To Assess Adverse Events and Drug to Drug Interaction of Oral Tablet Atogepant and Ubrogepant in Adult Participants With a History of Migraine	P1	completed	26	AbbVie	Mar 2021
NCT04179474		Safety, Tolerability and Drug- Drug Interaction Study of Ubrogepant With Erenumab or Galcanezumab in Participants With Migraine	P1	completed	40	Allergan	Sep 2019
NCT02873221		An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine	P3	completed	1,254	Allergan	Sep 2016
NCT02867709	ACHIEVE II	Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine	P3	completed	1,686	Allergan	Aug 2016
NCT02828020	ACHIEVE I	Efficacy, Safety, and Tolerability Study of Oral Ubrogepant in the Acute Treatment of Migraine	P3	completed	1,672	Allergan	Jul 2016

Ubrogepant clinical trials: frequently asked questions

How many Ubrogepant clinical trials are there?: 16 Ubrogepant clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 4 are actively recruiting participants. 10 are marked completed.
Are Ubrogepant clinical trials recruiting in 2026?: Yes — 4 Ubrogepant trials are actively recruiting in 2026, with 177 U.S. sites across 43 states. See the recruiting trials and the per-state site list further down this page.
What conditions is Ubrogepant being studied for?: Ubrogepant is being studied for Migraine, Migraine, With or Without Aura, Headache, Migraine, Healthy Volunteers, Interstitial Cystitis and 8 more. The trials are grouped by indication on this page.
What phase is Ubrogepant in?: Ubrogepant clinical trials span 3 Phase 4, 7 Phase 3, 4 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
Who sponsors Ubrogepant clinical trials?: The lead sponsor across the most Ubrogepant trials is AbbVie, with 6 additional lead sponsors listed in the data. Each trial row links to the full study detail page including sponsor information.

Sources and methodology

Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming Ubrogepantas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.

Last refreshed June 18, 2026.

Related pages on Hipa.ai:

Ubrogepant overview Ubrogepant evidence & publications